{"nct_id":"NCT02651727","title":"Ph 1 Study of VS-4718, a FAK Inhibitor, in Combination With Nab-paclitaxel and Gemcitabine in Advanced Cancer Subjects","status":"TERMINATED","status_verified_date":"2017-01","start_date":"2015-09","start_date_type":null,"primary_completion_date":"2017-01","primary_completion_date_type":"ACTUAL","completion_date":"2017-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["VSTM"]}